Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Cell Death & Disease|June 6, 2022
Nuclear p120 catenin is a component of the perichromosomal layer and coordinates sister chromatid segregation during mitosis in lung cancer cellsShu-Er Chow, Yaa-Jyuhn J Meir, Jhy-Ming Li, et al.Journal of Clinical Medicine|April 23, 2022
Comparison of Efficacy of 2% Chlorhexidine Gluconate-Alcohol and 10% Povidone-Iodine-Alcohol against Catheter-Related Bloodstream Infections and Bacterial Colonization at Central Venous Catheter Insertion Sites: A Prospective, Single-Center, Open-Label, Crossover StudyMing-Ru Lin, Po-Jui Chang, Ping-Chih Hsu, et al.Vaccines|July 2, 2021
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)Li-Chung Chiu, Shu-Min Lin, Yu-Lun Lo, et al.Vaccines|October 26, 2021
Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational StudyChin-Chou Wang, Li-Chung Chiu, Jia-Shiuan Ju, et al.BMC Cancer|July 28, 2021
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort studyChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.Cancers|February 15, 2022
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung AdenocarcinomaChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 24, 2024
Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapyPing-Chih Hsu, John Wen-Cheng Chang, Li-Chung Chiu, et al.Expert Review of Anticancer Therapy|November 28, 2017
Response to afatinib in treatment-naïve patients with advanced mutant epidermal growth factor receptor lung adenocarcinoma with brain metastasesShih-Hong Li, Chien-Ying Liu, Ping-Chih Hsu, et al.Oncology Reports|June 25, 2019
Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine modelPing-Chih Hsu, Bo Tian, Yi-Lin Yang, et al.Thoracic Cancer|May 28, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patientsJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.Pageof 8